Cyntellect

About:

Cyntellect provided products for cell analysis, purification, and processing technology to advance research and drug discovery.

Website: http://www.cyntellect.com

Twitter/X: home_one

Top Investors: Third Security, Bru Venture Capital

Description:

Cyntellect is dedicated to setting new standards in cell analysis, purification, and processing technology. Cyntellect's products support key applications to advance life science research, biopharmaceutical production, stem cell research and drug discovery. The Company's technology employs in situ, microplate-based cytometry to analyze cells with minimal sample manipulation, and process cells with great precision and efficiency. Cyntellect's expanding cellular analysis and processing portfolio is expected to play an enabling role in the coming age of advanced cell-based diagnostics and therapeutics.

Total Funding Amount:

$42.6M

Headquarters Location:

San Diego, California, United States

Founded Date:

1997-01-01

Contact Email:

info(AT)cyntellect.com

Founders:

Number of Employees:

11-50

Last Funding Date:

2010-07-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai